Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorTampere University
About this trial
This research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the costs of these alternative initiation methods are.
Eligibility criteria
Qualifiers
ALS diagnosed by a neurology and
chronic respiratory insufficiency or significant respiratory muscle weakness caused by ALS
Disqualifiers
impaired cognition to give informed consent to participation
contraindication to NIV therapy
another severe disease with a prognosis of less than one year
ventilation via an artificial airway, tracheostomy
Trial design
Treatments tested in this trial
- NIV initiation in patients with ALS
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Tampere University
Lead sponsor
Tampere University Hospital
Sponsor institution
Source ClinicalTrials.gov